Rigel Pharmaceuticals, Inc. (RIGL)

NASDAQ: RIGL · Real-Time Price · USD

45.71

-5.58 (-10.88%)

At close: Nov 5, 2026, 4:00 PM EST

41.74

-3.97 (-8.69%)

Pre-market: Nov 6, 2026, 4:24 AM EST

Rigel Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Revenue	287.95	294.02	179.28	115.78	115.74	138.74
Other Revenue	0.27	0.27	-	1.1	-	-
Revenue	288.21	294.28	179.28	116.88	115.74	138.74
Revenue Growth	2.18%	64.15%	53.38%	0.98%	-16.57%	27.73%
Cost of Revenue	63.16	52.92	42.03	31.63	62.02	66.32
Gross Profit	225.05	241.37	137.25	85.25	53.72	72.42
Selling, General & Admin	128.02	115.9	113.06	105.74	112.45	91.89
Operating Expenses	149.31	115.9	113.06	105.74	112.45	91.89
Operating Income	75.74	125.47	24.19	-20.49	-58.73	-19.48
Interest Expense	-4.17	-7.32	-7.92	-6.87	-3.71	-4.86
Interest & Investment Income	3.8	3.68	2.09	2.27	0.68	0.05
EBT Excluding Unusual Items	75.37	121.83	18.37	-25.09	-61.75	-24.29
Merger & Restructuring Charges	-	-	-	-	-1.32	-3.52
Other Unusual Items	-	-	-	-	4.5	10.5
Pretax Income	75.37	121.83	18.37	-25.09	-58.57	-17.31
Income Tax Expense	-231.83	-245.2	0.88	-	-	0.61
Net Income	307.19	367.02	17.49	-25.09	-58.57	-17.91
Net Income to Common	307.19	367.02	17.49	-25.09	-58.57	-17.91
Net Income Growth	171.13%	1999.08%	-	-	-	-
Shares Outstanding (Basic)	18	18	18	17	17	17
Shares Outstanding (Diluted)	20	19	18	17	17	17
Shares Change	9.34%	6.52%	1.64%	2.07%	-0.00%	1.03%
EPS (Basic)	16.63	20.40	0.99	-1.44	-3.44	-1.05
EPS (Diluted)	15.38	19.48	0.99	-1.44	-3.44	-1.05
EPS Growth	148.26%	1867.68%	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	89.93	75.66	31.44	-5.74	-74.21	5.25
Free Cash Flow Per Share	4.50	4.02	1.78	-0.33	-4.35	0.31
Gross Margin	78.08%	82.02%	76.56%	72.94%	46.41%	52.20%
Operating Margin	26.28%	42.63%	13.49%	-17.53%	-50.74%	-14.04%
Profit Margin	106.59%	124.72%	9.75%	-21.47%	-50.61%	-12.91%
Free Cash Flow Margin	31.20%	25.71%	17.53%	-4.91%	-64.11%	3.79%
EBITDA	79.57	127.88	26.42	-19.25	-57.73	-18.31
EBITDA Margin	27.61%	43.45%	14.74%	-16.47%	-49.88%	-13.20%
D&A For EBITDA	3.84	2.42	2.23	1.24	1	1.16
EBIT	75.74	125.47	24.19	-20.49	-58.73	-19.48
EBIT Margin	26.28%	42.63%	13.49%	-17.53%	-50.74%	-14.04%
Effective Tax Rate	-	-	4.80%	-	-	-
Revenue as Reported	288.21	294.28	179.28	116.88	120.24	149.24
Advertising Expenses	-	2.3	2.1	3.1	-	-

SEC Filings: 10-K · 10-Q